Clinical Trial Update: Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s) [Phase 3]

View source ↗

Summary

Phase 3 trial update on immunogenicity and safety of a tetravalent dengue vaccine in adolescents in non-endemic areas; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• Tetravalent Dengue Vaccine (TDV) (tetravalent dengue vaccine)

Snippet

Sponsor: Takeda | Conditions: Dengue | Phase 3 | Status: COMPLETED | Results posted: 2019-08-15